Latest Articles

This article will explore the tumor microenvironment, touching on the different cells and factors that comprise it, how tumors take advantage of it and how it can be therapeutically targeted.

This article highlights the importance of measuring potency for cell and gene therapies.

In this interview, we spoke to Dr. Izzy Jayasinghe, a senior lecturer and UK Research and Innovation future leader fellow at the University of Sheffield, to find out about her research and experiences as a transgender woman of color in STEM.

Flagella, cilia and pili are all similar in shape, however, each possesses a different structure and biological function. This article outlines the features of flagella, cilia and pili, including their structure and function, and explores the key differences between them.

From tweets to toots – the online community #SciTwitter is considering a move from Twitter to an alternative online platform. In this article, we explore how Twitter has supported science communication and outreach over recent years, the motivations for migration and ask: where are you heading, #SciTwitter?

By combining single-cell analysis tools with imaging and microfluidics, spatial biology is adding a new layer of information and is set to transform biomedical science.

Technology Networks recently had the pleasure of speaking with Dr. Sam Barichievy, director in cell engineering at the biopharmaceutical company AstraZeneca. In this conversation, Dr. Barichievy shares her perspectives on what equality, diversity and inclusion entails, and how fostering inclusive environments can enable us to do better science.

Dr. Jenna Macciochi is a lecturer in immunology at the University of Sussex, where her research centers on understanding the role that nutrition and lifestyle play in human immunity.

Recently, an expose article was published revealing a potential fabrication of data by prominent investigators of Alzheimer’s disease. In this op-ed piece, Michael Kinch explores the catastrophic impact of scientific fraud.

Over the last decade there has been a prolific “boom” in aging and anti-aging research, extending beyond academic work into biotech and big pharma. A new study calls the biomarkers used to track the benefits of "anti-aging" regimens, and to calculate biological age, into question.